The exploration of the druggability
of certain protein–protein
interactions (PPIs) still remains a challenging task in drug discovery.
Here, we present a case study using the 14-3-3-PPI, showing how small
molecules can be located that are able to modulate this key oncogenic
pathway. A workflow embracing biophysical techniques and MD simulations
was developed to evaluate the potential of a 14-3-3ζ PPI system
to bind new tool compounds. The significance of the use of computational
approaches to compensate for the limitations of experimental techniques
is demonstrated.